Product Information |
|
Registration Number |
BR-1406
|
Generic Name |
Insulin Aspart
|
Brand Name |
Fiasp
|
Dosage Strength |
100 Units (equivalent to 3.5 mg)/mL
|
Dosage Form |
Solution for
Injection (IV/SC)
|
Classification |
Prescription Drug (RX)
|
Packaging |
10 mL Type I glass vial with bromobutyl rubber stopper and aluminum flip-off cap (Box of 1's)
|
Pharmacologic Category |
Antidiabetics
|
Manufacturer |
Novo Nordisk Pharmaceutical Industries, LP
|
Country of Origin |
United States of America
|
Trader |
N/A
|
Importer |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Distributor |
Novo Nordisk Pharmaceuticals (Philippines), Inc.
|
Application Type |
Initial
|
Issuance Date |
14 July 2022
|
Expiry Date |
14 July 2027
|